Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso®, BVI’s first dual-function phaco-vitrectomy platform designed to deliver advanced control, efficiency, and...
-
WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Wir wurden von BVI Medical, Inc. darauf hingewiesen, dass Journalisten und andere Leser die Pressemitteilung „BVI gibt bekannt, dass Virtuoso®,...
-
WALTHAM, Mass., 20 avr. 2026 (GLOBE NEWSWIRE) -- BVI Medical, Inc. nous informe que les journalistes et autres lecteurs doivent ignorer le communiqué de presse publié le 20 avril 2026, « BVI annonce...
-
The med radiation shielding market size is expected to hit $ 3.2 BN by 2034 from its value of $ 1.6 BN in 2024, at a CAGR of 7.20% from 2025 to 2034.
-
Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes U.S. Roadside drug testing market projected to reach...
-
Rpharmy, a leading provider of healthcare software solutions, today announced it has completed its SOC® 2 Type II audit.
-
Life sciences consulting services market is projected to reach $ 29.6 BN by 2034 from its value of $ 14.1 BN in 2024, at a CAGR of 7.7% from 2025 to 2034
-
TYLER, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of...
-
NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel...
-
SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...